To hear about similar clinical trials, please enter your email below
Trial Title:
Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
NCT ID:
NCT05809128
Condition:
Breast Cancer Patients
Conditions: Official terms:
Breast Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
surgery for breast cancer and imaging test evaluations
Description:
At the time of surgery, having completed the evaluation extemporaneous of the surgical
piece, tissue samples will be collected to be stored from the material exceeding the
completion of the patients' diagnosis. In addition, paramenters that can be extracted
from radiodiagnostic images will be evaluated
Summary:
Prospective observational study for onco-immunologic characterization and by bioimaging
of breast neoplastic tissue of patients operated for breast cancer
Criteria for eligibility:
Study pop:
Breast cancer patients
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Clinical diagnosis of breast cancer.
- patients 25 to 80 years of age
Exclusion Criteria:
- Patients who refuse to participate in the study;
- Patients who do not fall within the age range mentioned above
Gender:
Female
Minimum age:
25 Years
Maximum age:
80 Years
Locations:
Facility:
Name:
IRCCS Synlab SDN
Address:
City:
Naples
Zip:
80143
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Laura Pierri, MSC
Phone:
0812408470
Email:
direzionescientifica.irccssdn@synlab.it
Start date:
May 29, 2019
Completion date:
June 30, 2025
Lead sponsor:
Agency:
IRCCS SYNLAB SDN
Agency class:
Other
Source:
IRCCS SYNLAB SDN
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05809128
